Altamira Therapeutics (CYTO) Short Interest Ratio & Short Volume $0.42 -0.01 (-2.31%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends Altamira Therapeutics Short Interest DataAltamira Therapeutics (CYTO) has a short interest of 31,100 shares, representing 0.83% of the float (the number of shares available for trading by the public). This marks a 168.10% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 102,382 shares to cover all short positions.Current Short Interest31,100 sharesPrevious Short Interest11,600 sharesChange Vs. Previous Month+168.10%Dollar Volume Sold Short$15,049.29Short Interest Ratio0.1 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares3,401,000 sharesFloat Size3,760,000 sharesShort Percent of Float0.83%Today's Trading Volume67,877 sharesAverage Trading Volume102,382 sharesToday's Volume Vs. Average66% Short Selling Altamira Therapeutics? Sign up to receive the latest short interest report for Altamira Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCYTO Short Interest Over TimeCYTO Days to Cover Over TimeCYTO Percentage of Float Shorted Over Time Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Altamira Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202431,100 shares $15,049.29 +168.1%0.8%0.1 $0.48 10/15/202411,600 shares $6,850.96 -50.9%0.3%0 $0.59 9/30/202423,600 shares $14,912.84 -71.2%0.6%0.1 $0.63 9/15/202482,000 shares $68,880.00 -54.5%2.2%0.2 $0.84 8/31/2024180,200 shares $160,756.42 +12.8%8.1%0.4 $0.89 8/15/2024159,800 shares $161,398.00 +20.4%7.2%0.1 $1.01 Get the Latest News and Ratings for CYTO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Altamira Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024132,700 shares $144,643.00 +15.8%6.0%0.1 $1.09 7/15/2024114,600 shares $152,418.00 -17.1%5.2%0.1 $1.33 6/30/2024138,200 shares $153,402.00 +34.3%6.2%0.1 $1.11 6/15/2024102,900 shares $124,509.00 -20.1%4.6%0.1 $1.21 5/31/2024128,800 shares $197,064.00 +27.4%5.8%0.1 $1.53 5/15/2024101,100 shares $154,683.00 -30.4%4.6%0.1 $1.53 4/30/2024145,200 shares $227,964.00 +67.5%6.6%0.1 $1.57 4/15/202486,700 shares $144,789.00 -80.5%3.9%0.1 $1.67 3/31/2024444,500 shares $920,115.00 +620.4%28.1%0.4 $2.07 3/15/202461,700 shares $106,741.00 +9.0%3.9%0.1 $1.73 2/29/202456,600 shares $106,408.00 -6.3%3.6%0.2 $1.88 2/15/202460,400 shares $112,948.00 -13.7%3.8%0.1 $1.87 1/31/202470,000 shares $129,500.00 +75.9%N/A0.1 $1.85 1/15/202439,800 shares $107,858.00 -29.1%N/A0 $2.71 12/31/202356,100 shares $195,228.00 -68.0%N/A0.1 $3.48 12/15/2023175,400 shares $650,734.00 -69.3%N/A0.2 $3.71 11/30/2023570,500 shares $223,179.60 +10.9%N/A0 $0.39 11/15/2023514,300 shares $50,915.70 +181.5%N/A0.1 $0.10 10/31/2023182,700 shares $27,003.06 +43.5%N/A0.2 $0.15 10/15/2023127,300 shares $30,233.75 +5.5%N/A0.3 $0.24 9/30/2023120,700 shares $29,511.15 +88.3%N/A0.4 $0.24 9/15/202364,100 shares $16,986.50 +33.5%N/A0.2 $0.27 8/31/202348,000 shares $17,275.20 -77.2%N/A0.2 $0.36 8/15/2023210,600 shares $80,028.00 -67.4%N/A0.4 $0.38 7/31/2023646,300 shares $245,594.00 +69.8%N/A1.1 $0.38 7/15/2023380,600 shares $146,911.60 +319.2%N/A0.3 $0.39 6/30/202390,800 shares $58,202.80 -16.5%N/A0 $0.64 6/15/2023108,700 shares $90,221.00 -47.4%N/A0 $0.83 5/31/2023206,600 shares $171,478.00 +140.0%N/A0.1 $0.83 5/15/202386,100 shares $80,572.38 -9.9%N/A0 $0.94 4/30/202395,600 shares $91,776.00 -92.0%N/A0 $0.96 4/15/20231,200,000 shares $1.36 million +253.5%N/A0.7 $1.13 3/31/2023339,500 shares $434,560.00 +5.1%31.2%0.3 $1.28 3/15/2023323,100 shares $429,723.00 +1,240.7%29.6%0.6 $1.33This Bull Market Indicator called NVDA at $116 (Ad)Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here 2/28/202324,100 shares $57,840.00 +61.7%2.2%0.1 $2.40 2/15/202314,900 shares $39,336.00 +86.3%1.3%0.4 $2.64 1/31/20238,000 shares $22,080.00 -57.5%0.7%0.2 $2.76 1/15/202318,800 shares $97,760.00 -49.9%1.7%0.2 $5.20 12/30/202237,500 shares $181,875.00 +73.6%3.4%0.3 $4.85 12/15/202221,600 shares $110,160.00 -18.5%2.1%0.2 $5.10 11/30/202226,500 shares $149,725.00 +16.7%2.6%0.3 $5.65 11/15/202222,700 shares $130,525.00 -76.7%2.2%0.2 $5.75 10/31/202297,400 shares $728,552.00 +435.2%9.7%1 $7.48 10/15/202218,200 shares $107,452.80 -95.1%0.1%0.2 $5.90 9/30/2022371,000 shares $107,552.90 +69.2%2.6%0.3 $0.29 9/15/2022219,300 shares $85,066.47 -57.5%1.5%0.2 $0.39 8/31/2022516,300 shares $188,965.80 +17.0%3.5%0.4 $0.37 8/15/2022441,300 shares $216,237.00 -46.7%3.0%0.3 $0.49 7/31/2022828,600 shares $364,584.00 +115.8%5.7%0.7 $0.44 7/15/2022383,900 shares $180,586.56 -11.8%2.6%0.3 $0.47 6/30/2022435,400 shares $211,299.62 -1.9%3.0%0.4 $0.49 6/15/2022444,000 shares $251,259.60 +30.7%3.0%0.4 $0.57 5/31/2022339,800 shares $249,413.20 +181.1%2.4%0.3 $0.73 5/15/2022120,900 shares $90,191.40 -62.2%0.8%0.1 $0.75 4/30/2022320,100 shares $284,889.00 -55.4%2.2%0.3 $0.89 4/15/2022717,300 shares $738,819.00 +64.3%4.9%0.6 $1.03 3/31/2022436,500 shares $480,150.00 -60.0%3.0%0.9 $1.10 3/15/20221,090,000 shares $912,221.00 +3,952.0%7.5%1.1 $0.84 2/28/202226,900 shares $26,232.85 -53.5%0.4%0 $0.98 2/15/202257,900 shares $70,638.00 -66.4%0.9%0.1 $1.22 1/31/2022172,200 shares $223,860.00 -52.7%2.6%0 $1.30 1/15/2022363,800 shares $600,270.00 -72.2%5.4%0.1 $1.65 12/31/20211,310,000 shares $2.38 million +1,073.8%19.5%0.3 $1.82 12/15/2021111,600 shares $147,312.00 -75.3%1.7%0 $1.32 11/30/2021452,100 shares $800,217.00 +495.7%6.7%0.1 $1.77 11/15/202175,900 shares $182,160.00 +19.5%1.1%0 $2.40 10/29/202163,500 shares $104,140.00 +212.8%0.9%0.3 $1.64 10/15/202120,300 shares $37,961.00 -51.9%0.3%0 $1.87 9/30/202142,200 shares $84,822.00 -19.5%0.6%0.1 $2.01 9/15/202152,400 shares $118,948.00 -26.9%0.8%0.1 $2.27 8/31/202171,700 shares $193,590.00 -51.3%1.1%0.1 $2.70 8/13/2021147,200 shares $447,488.00 No Change2.2%0.1 $3.04 CYTO Short Interest - Frequently Asked Questions What is Altamira Therapeutics' current short interest? Short interest is the volume of Altamira Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 31,100 shares of CYTO short. 0.83% of Altamira Therapeutics' shares are currently sold short. Learn More on Altamira Therapeutics' current short interest. What is a good short interest percentage for Altamira Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.83% of Altamira Therapeutics' floating shares are currently sold short. Is Altamira Therapeutics' short interest increasing or decreasing? Altamira Therapeutics saw a increase in short interest in October. As of October 31st, there was short interest totaling 31,100 shares, an increase of 168.1% from the previous total of 11,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Altamira Therapeutics' float size? Altamira Therapeutics currently has issued a total of 3,401,000 shares. Some of Altamira Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Altamira Therapeutics currently has a public float of 3,760,000 shares. How does Altamira Therapeutics' short interest compare to its competitors? 0.83% of Altamira Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Altamira Therapeutics: Cardio Diagnostics Holdings, Inc. (7.65%), Hoth Therapeutics, Inc. (9.08%), Biomerica, Inc. (3.34%), Upexi, Inc. (22.07%), Aeterna Zentaris Inc. (0.18%), Orgenesis Inc. (0.29%), Organovo Holdings, Inc. (0.95%), Alzamend Neuro, Inc. (5.25%), Aptevo Therapeutics Inc. (6.48%), Cyclerion Therapeutics, Inc. (0.69%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Altamira Therapeutics stock? Short selling CYTO is an investing strategy that aims to generate trading profit from Altamira Therapeutics as its price is falling. CYTO shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Altamira Therapeutics? A short squeeze for Altamira Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CYTO, which in turn drives the price of the stock up even further. How often is Altamira Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CYTO, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Cardio Diagnostics Short Interest Hoth Therapeutics Short Interest Biomerica Short Interest Upexi Short Interest Aeterna Zentaris Short Interest Orgenesis Short Interest Organovo Short Interest Alzamend Neuro Short Interest Aptevo Therapeutics Short Interest Cyclerion Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CYTO) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Altamira Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Altamira Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYTO Stock Alerts